Table 2.
Association of strongly positive resistin expression with clinical pathologic parameters in patients with colorectal cancer.
| Variables | No. | Strongly positive resistin expression, n (%) | P value |
|---|---|---|---|
| Gender | |||
| Male | 215 | 57 (26.5%) | 0.609 |
| Female | 145 | 42 (29.0%) | |
| Age (years) | |||
| <60 | 102 | 30 (29.4%) | 0.609 |
| ≥60 | 258 | 69 (26.7%) | |
| Tumor site | |||
| Right colon | 87 | 27 (31.0%) | 0.622 |
| Left colon | 82 | 20 (24.4%) | |
| Rectum | 191 | 52 (27.2%) | |
| Tumor grade | |||
| High | 36 | 12 (33.3%) | 0.686 |
| Medium | 288 | 78 (27.1%) | |
| Low | 36 | 9 (25.0%) | |
| Depth of invasion | |||
| Tis+T1/T2 | 61 | 11 (18.0%) | 0.069 |
| T3/T4 | 299 | 88 (29.4%) | |
| Lymph node metastases | |||
| - | 200 | 44 (22.0%) | 0.009 |
| + | 160 | 55 (34.4%) | |
| Tumor stage | |||
| I | 42 | 5 (11.9%) | 0.022 |
| II | 151 | 37 (24.5%) | |
| III | 141 | 49 (34.8%) | |
| IV | 26 | 8 (30.8%) |